FIVE PRIME THERAPEUTICS INC - COM (FPRX)

CUSIP: 33830X104

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / COM
Total 13F shares
18,615,605
Share change
+4,935,164
Total reported value
$425,488,294
Price per share
$22.85
Number of holders
90
Value change
+$106,161,341
Number of buys
70
Number of sells
18

Quarterly Holders Quick Answers

What is CUSIP 33830X104?
CUSIP 33830X104 identifies FPRX - FIVE PRIME THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FIVE PRIME THERAPEUTICS INC - COM (FPRX) as of Q1 2015

As of 31 Mar 2015, FIVE PRIME THERAPEUTICS INC - COM (FPRX) was held by 90 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,615,605 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, ADAGE CAPITAL PARTNERS GP LLC, STATE STREET CORP, Versant Venture Management, LLC, MILLENNIUM MANAGEMENT LLC, Point72 Asset Management, L.P., BlackRock Fund Advisors, EVENTIDE ASSET MANAGEMENT, LLC, PRICE T ROWE ASSOCIATES INC /MD/, and VANGUARD GROUP INC. This page lists 90 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.